ConductScience.org, home

Trial · NCT00308737

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual CareBaseline to Month 24Change from Baseline to End of Study in FEV1 by MMRM
PrimaryFEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual CareBaseline to Month 24FEV1 decrease of ≥ 15% from Baseline value at last measurement
SecondaryChange From Baseline to Last Measurement in FEV1 for TI vs Usual CareBaseline to Month 24Change from Baseline to last measurement(Month 24) in FEV1
SecondaryChange From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRMBaseline to Month 24Change from Baseline to Month 24 in FVC by MMRM
SecondaryChange From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRMBaseline to Month 24Change from baseline to Month 24 in TLC by MMRM
SecondaryChange From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRMBaseline to Month 24Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM
SecondaryForced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last MeasurementBaseline to Month 24FVC Decrease of ≥15% from Baseline Value at Last Measurement
SecondaryTotal Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last MeasurementBaseline to Month 24TLC Decrease of ≥ 15% from Baseline Value at Last Measurement
SecondaryHemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last MeasurementBaseline to Month 24Hemoglobin-corrected DLco decrease of ≥ 15% from baseline value at last measurement
SecondaryHemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of >3 ml/Min/mmHg From Baseline Value at Last MeasurementBaseline to Month 24Hemoglobin-corrected DLco decrease of \>3 ml/min/mmHg from baseline value at last measurement
SecondaryChange From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual CareBaseline to Month 24Change from baseline in HbA1c at last measurement
SecondaryChange in Weight From Baseline at Month 24Baseline to Month 24Change from baseline in weight at Month 24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00308737/registered